Showing results (1631-1640 of 2,368) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|February 15, 2025
Benzo[a]phenoselenazine-based NIR photodynamic therapy for the treatment of COX-2 overexpressing cancer cellsKalayou Hiluf GebremedhinFuture Medicinal Chemistry|February 12, 2025
Advances of deep Neural Networks (DNNs) in the development of peptide drugsYuzhen Niu, Pingyang Qin, Ping LinFuture Medicinal Chemistry|January 21, 2025
Key molecular scaffolds in the development of clinically viable α-amylase inhibitorsRahul Singh, Jayant Sindhu, Devender Singh, et al.Future Medicinal Chemistry|January 29, 2025
A series of benzensulfonamide derivatives as new potent carbonic anhydrase IX and XII inhibitorsSusanna Nencetti, Doretta Cuffaro, Lidia Ciccone, et al.Future Medicinal Chemistry|January 17, 2025
The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapyXinlan Hu, Yan Wu, Mengmeng Yao, et al.Future Medicinal Chemistry|November 7, 2024
Design, synthesis and mechanistic exploration of anti-plasmodial Indolo[2,3-b]quinoxaline-7-chloroquinoline hybridsShefali Chowdhary, Shagun Arora, Isabelle Fonta, et al.Future Medicinal Chemistry|November 28, 2024
Environment benign synthesis of 5-acyl-4-hydroxypyridin-2(1H)-one derivatives as antioxidant and α-amylase inhibitorsNeelam Yadav, Ravi Kumar, Sarita Sangwan, et al.Future Medicinal Chemistry|March 19, 2025
Spirocyclic compounds: potential drug leads in the fight against Mycobacterium tuberculosisPardeep Kumar, Anuradha Singampalli, Rani Bandela, et al.Future Medicinal Chemistry|March 13, 2025
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentialsBasma S Gabr, Abdelrahman R Shalabi, Mona F Said, et al.Future Medicinal Chemistry|October 15, 2024
In silico studies, synthesis, characterization and in vitro studies of levosulpiride derivativesMuhammad Toseef Akram, Mohsin Abbas Khan, Irshad Ahmad, et al.Pageof 237